Replies to post #440144 on NorthWest Biotherapeutics Inc (NWBO)

[DavidW2]

There is no need to uplist. If TLD+ Publication is great, then buyout or partnership is coming, there is no need to uplist.

[Maverick0408]

My expectation is TLD+publication this quarter. This will help build trust and transparency in my view. I’m willing to be more flexible & supportive of the next steps once they produce that data point this quarter.

My personal belief is that they won’t do RS or uplist… I will stick with my buyout theory soon after FDA approval….on the other hand, if the results are iffy (highly unlikely) then I am not sure they will have many supporters left given the history of the trial and how they have handled this…either way, RS or uplist won’t happen, but again all IMO!